Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Sialic Acid as a Novel Biomarker in the Diagnosis of Hepatocellular Carcinoma

NCT06836518 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT06836518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06836518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Sialic Acid as a Novel Biomarker in the Diagnosis of Hepatocellular Carcinoma
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
May 1, 2026
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma